- Hughes BM, Holland A, Hödebeck-Stuntebeck N, Garrick L, Goldstone AP, Lister M, Moore C, Hughes M. Body weight, behaviours of concern, and social contact in adults and adolescents with Prader-Willi syndrome in full-time care services: Findings from pooled international archival data Orphanet J Rare Dis
- Cortés-Martín A, Iglesias-Aguirre CE, Marín A, Romo-Vaquero M, Vallejo F, Espín JC, Victoria Selma M. Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals Food Funct
-
le Roux CW, Steen O, Lucas KJ, Startseva E, Unseld A, Hennige AM.
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial Lancet Diabetes Endocrinol
- Steenackers N, Feldman AN, Mathieu C, Rosen J, Soderberg J, Al-Ozairi E, le Roux CW, Van der Schueren B. The double burden: Navigating type 1 diabetes and obesity Clin Obes
-
Musumeci A, McElwain CJ, Manna S, McCarthy F, McCarthy C.
Exposure to gestational diabetes mellitus increases subclinical inflammation mediated in part by obesity Clin Exp Immunol
- Nicholls SJ, Tofé S, le Roux CW, D'Alessio DA, Wiese RJ, Pavo I, Brown K, Weerakkody GJ, Zeytinoglu M, Romera IC. Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program Cardiovasc Diabetol
-
Reger C, Leitzmann MF, Rohrmann S, Kühn T, Sedlmeier AM, Jochem C.
Sustainable diets and risk of overweight and obesity: A systematic review and meta-analysis Obes Rev
-
O'Reilly SL, McNestry C, McGuinness D, Killeen SL, Mehegan J, Coughlan B, O'Brien EC, O'Brien D, Szafranska M, Brosnan M, Sheehy L, Murtagh R, O'Hagan L, Corbett M, Walsh M, Keogh R, Power P, Woodcock M, Phelan M, Carroll A, Murray S, Scallan C, Dunn E, M
Multicomponent perinatal breastfeeding support in women with BMI >25: The Latch On multi-centre randomised trial BJOG
-
Purnell JQ, le Roux CW.
Hypothalamic control of body fat mass by food intake: The key to understanding why obesity should be treated as a disease Diabetes Obes Metab
-
Jakubowska A, Roux CWL, Viljoen A.
The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor – An Update Endocrinol Metab (Seoul)